ARCHIVES

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

ONS Annual Meeting To Highlight Nursing Progress In ‘70s, ‘80s

April 20, 1990

In Brief: Parkinson To Leave CTEP For Novartis; FTC To Permit Sandoz, Ciba-Geigy Merger

January 10, 1997

ACS Medals Of Honor To Bonadonna, Hsu, Louis Sullivan

December 13, 1991

Triple-Negative Breast Cancer Equally Aggressive in Whites

February 25, 2011

Neutron Therapy Contracts Wind Down Next Year; DCT To Consider Whether To Continue Support

March 25, 1988

Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival

April 25, 2014